TARIFFS LATEST US, China to slash tariffs for 90 days NasdaqCM - Nasdaq Real Time Price • USD P3 Health Partners Inc. (PIII) Follow Add holdings 8.50 -0.21 (-2.41%) As of 9:44:00 AM EDT. Market Open. All News Press Releases SEC Filings P3 Health Partners Schedules First Quarter 2025 Earnings Release and Conference Call HENDERSON, Nev., May 08, 2025--P3 Health Partners Inc. ("P3") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for first quarter 2025 and file its Quarterly Report on Form 10-Q on Thursday, May 15, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. P3 Health Partners to Participate in the 24th Annual Needham Virtual Healthcare Conference HENDERSON, Nev., April 02, 2025--P3 Health Partners Inc. ("P3") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming 24th Annual Needham Virtual Healthcare Conference. P3 Health Partners Inc (PIII) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst Challenges P3 Health Partners Inc (PIII) reports a 7% revenue increase and reaffirms 2025 guidance despite facing elevated medical expenses and EBITDA losses. P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results HENDERSON, Nev., March 27, 2025--P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient- centered and physician-led population health management company, today announced its financial results for the fourth quarter and full year ended December 31, 2024, and affirmed its 2025 guidance. P3 Health Partners to Report Fourth Quarter and Full Year 2024 Financial Results on March 27 HENDERSON, Nev., March 13, 2025--P3 Health Partners Inc. ("P3") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for the fourth quarter and full year 2024 on March 27, 2025. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. P3 Health Partners to Participate in the TD Cowen 45th Annual Health Care Conference HENDERSON, Nev., February 19, 2025--P3 Health Partners Inc. ("P3") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming TD Cowen 45th Annual Health Care Conference in Boston, Massachusetts. P3 Health Partners Provides Preliminary 2025 Guidance and Announces Proposed Financing Transaction HENDERSON, Nev., February 13, 2025--P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered, physician-led population health management company, is targeting profitability in 2025, with initial revenue guidance for the year of $1.350 billion to $1.500 billion and Adjusted EBITDA of negative ($35) million to $5 million. P3 Health Partners to Present at the 43rd Annual J.P. Morgan Healthcare Conference HENDERSON, Nev., January 13, 2025--P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced it will participate at the upcoming J.P. Morgan Healthcare Conference in San Francisco, California. P3 Health Partners to Present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference HENDERSON, Nev., November 27, 2024--P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that management is scheduled to present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference, on Tuesday, December 3, 2024, in Boca Raton, FL, at 3:30 pm Eastern Time. P3 Health Partners to Participate in Upcoming Investor Conferences HENDERSON, Nev., November 20, 2024--P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced the Company will participate in the following upcoming investor conferences: Analysts Have Lowered Expectations For P3 Health Partners Inc. (NASDAQ:PIII) After Its Latest Results There's been a major selloff in P3 Health Partners Inc. ( NASDAQ:PIII ) shares in the week since it released its... P3 Health Partners Inc (PIII) Q3 2024 Earnings Call Highlights: Navigating Growth and Challenges P3 Health Partners Inc (PIII) reports strong revenue growth amidst operational challenges and strategic realignments. P3 Health Partners Announces Third Quarter 2024 Results HENDERSON, Nev., November 12, 2024--P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2024. P3 Health Partners Schedules Third Quarter 2024 Earnings Release and Conference Call HENDERSON, Nev., October 29, 2024--P3 Health Partners Inc. ("P3") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for third quarter 2024 and file its Quarterly Report on Form 10-Q on Tuesday, November 12, 2024. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day. P3 Health Partners to Present at the LD Micro Main Event XVII HENDERSON, Nev., October 17, 2024--P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced that management is scheduled to present at the LD Micro Main Event XVII Conference on Wednesday, October 30, 2024, in Los Angeles, CA, at 2:30 pm Eastern Time. P3 Health Partners Inc (PIII) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ... P3 Health Partners Inc (PIII) reports a 15% revenue increase and a 50% improvement in adjusted EBITDA loss, showcasing robust financial progress. P3 Health Partners Names Leif Pedersen New Chief Financial Officer HENDERSON, Nev., August 29, 2024--P3 Health Partners Inc. ("P3") (NASDAQ: PIII), a patient-centered and physician-led population health management company, announced today that Leif Pedersen, an experienced finance, operational and value-based care executive, will join the company as chief financial officer (CFO) effective October 1, 2024. Pedersen succeeds Atul Kavthekar, who will continue as CFO until September 30, 2024, after which he will serve as a Strategic Advisor to the company. P3 Health Partners Inc.'s (NASDAQ:PIII) market cap dropped US$9.5m last week; Private equity firms bore the brunt Key Insights Significant control over P3 Health Partners by private equity firms implies that the general public has... P3 Health Partners to Present at Upcoming Investor Conferences HENDERSON, Nev., August 21, 2024--P3 Health Partners Inc. ("P3") (NASDAQ: PIII), a patient-centered and physician-led population health management company will participate at the following upcoming investor conferences: P3 Health Partners Announces Second Quarter 2024 Results HENDERSON, Nev., August 07, 2024--P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2024. Performance Overview Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) Return PIII S&P 500 (^GSPC) YTD -24.44% -0.83% 1-Year -74.70% +11.69% 3-Year -96.59% +48.42%